Elicio Therapeutics, Inc. (ELTX)
10.67
+0.02
(+0.19%)
USD |
NASDAQ |
Apr 06, 16:00
10.65
-0.02
(-0.19%)
After-Hours: 20:00
Elicio Therapeutics SG&A Expense (TTM) : 12.81M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aura Biosciences, Inc. | 22.49M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Savara, Inc. | 42.06M |
| BioMarin Pharmaceutical, Inc. | 1.153B |